Form 4: Lilly Endowment Inc. Sells Shares in Eli Lilly & Co.
SEC Form 4 Filing
Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., has sold a portion of its holdings in multiple transactions on June 14, 2024.
Summary
- Lilly Endowment Inc. sold 12,363 shares of Eli Lilly & Co. common stock at a weighted average price of $882.277 per share on June 14, 2024.
- These shares were sold in multiple transactions with prices ranging from $882.00 to $882.955.
- Additionally, Lilly Endowment Inc. sold 2,659 shares of Eli Lilly & Co. common stock at a weighted average price of $883.377 per share on the same day.
- These shares were also sold in multiple transactions with prices ranging from $883.03 to $883.795.
- Following these transactions, Lilly Endowment Inc. beneficially owns 97,778,788 shares of Eli Lilly & Co. common stock.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock sale, with no indication of positive or negative sentiment. It is a routine transaction.
Industry Context
This filing reflects a routine transaction by a major shareholder and is typical for large institutional investors managing their portfolios. It does not indicate any specific trend or issue within the pharmaceutical industry.
Comparison to Industry Standards
- Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders and major shareholders in publicly traded companies.
- The transaction size is relatively small compared to the overall holdings of Lilly Endowment Inc., suggesting a minor portfolio adjustment rather than a significant shift in investment strategy.
- Similar transactions are common among large institutional investors in other pharmaceutical companies such as Pfizer (PFE) and Johnson & Johnson (JNJ).
Stakeholder Impact
- The sale of shares by Lilly Endowment Inc. may have a minor impact on the stock price of Eli Lilly & Co., but is unlikely to cause significant volatility due to the relatively small transaction size.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of the stock sale transactions. |
| 06/17/2024 | Date the Form 4 was signed. |
Keywords
Eli Lilly & Co, Lilly Endowment Inc, share sale, stock transaction, beneficial ownership, LLY
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.